Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention AI, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Wave, all published on March 23, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention AI, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Wave, all published on March 23, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Wave. Shared-story counts are live from our verified record — not editorial picks.
Cearvol has officially launched Wave, a professional-grade hearing aid that integrates artificial intelligence and a touchscreen interface. This award-winning device aims to improve accessibility and user confidence for millions suffering from hearing loss through real-time environmental adaptation.
Source: in.marketscreener.com · au.marketscreener.com
Wave is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
